EP
SGHT icon

Essential Partners’s Sight Sciences SGHT Stock Holding History

Essential Partners’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$965 Buy
178
+62
+53% +$285 ﹤0.01% 2261
2026
Q1 		$437 Buy
116
+6
+5% +$32 ﹤0.01% 2474
2025
Q4 		$872 Sell
110
-10
-8% -$64 ﹤0.01% 2074
2025
Q3 		$413 Buy
120
+25
+26% +$93 ﹤0.01% 2258
2025
Q2 		$392 Buy
+95
New +$317 ﹤0.01% 1766

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Essential Partners's SGHT Position: Q2 2026 in Review

Essential Partners increased its Sight Sciences (SGHT) stake by 53% in Q2 2026, buying an estimated $285 and bringing the position to 178 shares worth $965. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

Essential Partners first reported a position in SGHT in Q2 2025 and has held it in 5 quarters since. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Essential Partners held 178 shares of Sight Sciences worth $965 as of Q2 2026.
  • Essential Partners bought 62 Sight Sciences shares in Q2 2026, an estimated $285.
  • Sight Sciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2261 holding.
  • Essential Partners first reported a position in Sight Sciences in Q2 2025 and has held it in 5 quarters since.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.